Task Group Charge

To identify and develop best practices for scalable screening models that also overcome barriers to the delivery of high quality lung cancer screening.

Leadership

Charles White, MD

Task Group Chair
University of Maryland

Peter Mazzone, MD, MPH

Task Group Vice Chair
Steering Committee Member
Cleveland Clinic

Task Group Members

Carolyn Aldigé
Prevent Cancer Foundation

Paul Doria-Rose, DVM, PhD*
National Cancer Institute

Debra Dyer, MD
National Jewish Health

Joelle Fathi, DNP, RN, ARNP, CTTS*
University of Washington School of Nursing

Laurie Fenton Ambrose*
GO2 Foundation for Lung Cancer

Grant Greenberg, MD, MHSA, MA
Lehigh Valley Health Network (Pennsylvania)

Claudia Henschke, PhD, MD
Icahn School of Medicine at Mount Sinai

Danny Hughes, PhD
Harvey L. Neiman Health Policy Institute

Jane Kim, MD, MPH*
Veterans Health Administration

Christopher Lathan, MD, MS, MPH
Dana-Farber Medical Institute at St. Elizabeth’s Medical Center

Bryan Loy, MD, MBA*
Humana

Andrea McKee, MD
Lahey/Beth Israel Lahey Health

James Mulshine, MD
Rush University Medical Center

Robert Nicklas
Life and Breath

Bruce Pyenson, FSA, MAAA
Milliman

Debra Ritzwoller, PhD
Kaiser Permanente

Lillie Shockney, RN, BS, MAS
Academy of Oncology Nurse and Patient Navigators

Carey Thomson, MD, MPH, FCCP
Mt. Auburn Hospital

Renda Wiener, MD, MPH
Boston University School of Medicine

Celeste Worth, MCHES
LuCa National Training Network

(*) indicates Steering Committee member

Opportunities for Intervention/Influence:

  • Identify best practices/challenges in established lung cancer screening programs
  • Define and regularly update alternative pathways and minimum standards to high quality lung cancer screening programs that include primary care, pulmonology, and radiology, and access to multidisciplinary groups
  • Provide a forum for feedback from health plans, FQHCs, VA, other coverage groups